James Karrels - 15 Feb 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
SVP, CFO and Secretary
Signature
Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
15 Feb 2025
Net transactions value
-$14,822
Form type
4
Filing time
19 Feb 2025, 16:29:59 UTC
Previous filing
11 Feb 2025
Next filing
10 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +14,998 +8.4% $0.000000 192,591 15 Feb 2025 Direct F1, F2
transaction MGNX Common Stock Tax liability $14,822 -5,790 -3% $2.56 186,801 15 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -14,998 -50% $0.000000 14,999 15 Feb 2025 Common Stock 14,998 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2023, the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2 Owned jointly with reporting person's wife.